NOXXON Pharma N.V.: Half-yearly Report on the Liquidity Contract With Invest Securities
NOXXON Pharma N.V. (Paris:ALNOX) (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that pursuant to the liquidity contract entrusted to Invest Securities by NOXXON Pharma N.V. the following assets appeared on the liquidity account:
As of December 31, 2019:
Number of shares: 14,540
Cash balance of the liquidity account: (EURO) 31,...